Andrew Gergely, MD
Psychiatry · Dunkirk, MDNPI 1336144831
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 604 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 604 payments — averaging $12.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sunovion Pharmaceuticals Inc.$1K
- Lundbeck LLC$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$745
- Supernus Pharmaceuticals, Inc.$698
- Alkermes, Inc.$368
- plus $1K from 15 others
What the payments were for
- Food & beverage$7,27098%
- Education$1402%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 138 | $1,496 |
| Sunovion Pharmaceuticals Inc. | 118 | $1,477 |
| Lundbeck LLC | 78 | $1,170 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 46 | $745 |
| Supernus Pharmaceuticals, Inc. | 127 | $698 |
| Alkermes, Inc. | 18 | $368 |
| Vanda Pharmaceuticals Inc. | 11 | $283 |
| Otsuka America Pharmaceutical, Inc. | 12 | $241 |
| Collegium Pharmaceutical, Inc. | 19 | $215 |
| Axsome Therapeutics, Inc. | 9 | $200 |
| Tris Pharma Inc | 8 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| E.r. Squibb & Sons, L.L.C. | 2 | $69 |
| Ironshore Pharmaceuticals Inc. | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| Eisai Inc. | 3 | $44 |
| TMS Neurohealth Centers Inc. | 2 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Noven Therapeutics, LLC | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $16 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$7,410 in reported general payments places this provider in the 90th percentile of 851 psychiatry providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 16 | $16,293 |
| Clozapine | 98 | $8,304 |
| Bupropion XlBupropion Hcl | 200 | $8,040 |
| Aripiprazole | 105 | $7,118 |
| Oxcarbazepine | 81 | $6,687 |
| Duloxetine Hcl | 166 | $6,024 |
| Trazodone Hcl | 272 | $5,768 |
| Divalproex Sodium ErDivalproex Sodium | 69 | $5,195 |
| Quetiapine Fumarate | 250 | $5,169 |
| Buspirone Hcl | 162 | $4,848 |
| Hydroxyzine Hcl | 138 | $4,600 |
| Gabapentin | 147 | $4,479 |
| Sertraline Hcl | 303 | $3,302 |
| Hydroxyzine Pamoate | 90 | $2,803 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 91 | $2,617 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Dunkirk
- John VaethBaltimore$2.1M
- Scott AaronsonBaltimore$334K
- Jamal FawazHagerstown$321K
- Thomas LaughrenRockville$283K
- Adam RothAnnapolis$210K
- Robert LehmanBaltimore$140K
- Karen AndersonBaltimore$117K
- Orlando DavisBaltimore$104K
- Paul LeberPotomac$85K
- Akira SawaBaltimore$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.